4883Modalis Therapeutics Corporation4883 info
$0.63info-2.91%24h
Global rank28259
Market cap$20.03M
Change 7d-11.50%
YTD Performance-16.67%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Modalis Therapeutics Corporation (4883) Stock Overview

    Modalis Therapeutics Corporation engages in the research and development of therapeutics to treat patients with serious genetic disorders. It is developing therapies for genetic diseases using its proprietary CRISPR-GNDM technology that enables to control gene expressions through modulating the switch (epigenetics of a specific locus. The company has a. joint research agreement with JCR Pharmaceuticals Co., Ltd. to evaluate the drug delivery technology of the gene therapy to the central nervous system (CNS) assuming CNS diseases as a target. The company was formerly known as EdiGENE Corporation and changed its name to Modalis Therapeutics Corporation in August 2019. Modalis Therapeutics Corporation was founded in 2016 and is headquartered in Tokyo, Japan.

    4883 Stock Information

    Symbol
    4883
    Address
    Y’s BuildingTokyo, 103-0026Japan
    Founded
    -
    Trading hours
    -
    Website
    https://modalistx.com
    Country
    🇯🇵 Japan
    Phone Number

    Modalis Therapeutics Corporation (4883) Price Chart

    -
    Value:-

    Modalis Therapeutics Corporation Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.6342562162976068
    N/A
    Market Cap
    $20.03M
    N/A
    Shares Outstanding
    31.58M
    N/A
    Employees
    36.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org